Gene Therapy
AMT Appoints New Chief Executive Officer
Published in Gene Therapy Weekly, October 8th, 2009
Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in human gene therapy, announced the appointment of Jorn Aldag as its new Chief Executive Officer, starting October 5. Mr. Aldag has a strong record of accomplishments in the life sciences sector and more than twenty five years of experience in corporate management and finance. As former President and CEO of Evotec AG, he was instrumental in transforming the company from a technology provider to one of the leading drug discovery and development companies in Europe.
Prof. Sander van Deventer will step down as interim-CEO of AMT. He will continue to contribute to AMT as Scientific Advisor.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2009-10-08)
More Articles from Gene Therapy Weekly
- Adenovirus
Scientists at Children's Hospital detail research in adenovirus - Angiogenesis
New angiogenesis research reported from Harvard University, Medical Department - Breast Cancer
Scientists at University of Colorado publish research in breast cancer - Cancer Gene Therapy
Reports summarize cancer gene therapy research from J. Martinezquintanilla and co-authors - Colon Cancer
New colon cancer findings from University of Texas described - Enzyme Research
Reports from C. Ampomahdwamena et al highlight recent research in enzyme research - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
